Temporary Atrial Pacing
Bradycardia, hypotension, sick sinus syndrome
CommercialActive
Key Facts
Indication
Bradycardia, hypotension, sick sinus syndrome
Phase
Commercial
Status
Active
Company
About CardioCommand
CardioCommand is a private medical device company commercializing a patented transesophageal technology for cardiac pacing and monitoring. Its core TAP technology leverages the esophagus's proximity to the heart to provide a minimally invasive alternative for temporary atrial pacing, stress testing, and electrophysiology studies. The company's products are used by leading hospitals and medical centers across the United States, indicating established clinical adoption. While the initial data mentions a veterinary product (petMAP), the primary focus from the website is on human medical applications in anesthesia, cardiology, and electrophysiology.
View full company profile